Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound anget for reducing weight, fat, sugar, pressure and for preventing and treating osteoporosis

A compound preparation and osteoporosis technology, applied in the field of medicine, can solve the problem of not implementing compound preparations, etc.

Inactive Publication Date: 2007-10-31
ZHONGSHAN UNICARE NATURAL MEDICINE +1
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although Chinese patent CN1349795A discloses a scheme of a compound preparation for human body weight loss prepared by conjugated linoleic acid and L-carnitine, however, since conjugated linoleic acid is an oily substance, and L-carnitine is a solid substance , did not implement its real compound preparation in its patent. The so-called compound preparation in the patent is to make conjugated linoleic acid into soft capsules and L-carnitine into hard capsules. The human body takes these two products at the same time
Moreover, the patent only discloses that its products can be used for human body weight loss

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Embodiment 1, calcium conjugated linoleate hard capsule

[0064] Material weighing: conjugated calcium linoleate 1500g (containing cis 9, trans 11-octadecadienoic acid calcium and trans 10, the weight percent of the isomers of cis 12-octadecadienoic acid calcium content 85%), L-carnitine 500g, tea polyphenols 0.3g, hydroxypropyl cellulose 10g, microcrystalline cellulose 10g, magnesium stearate 5g.

[0065] Mix the weighed calcium conjugated linoleate, L-carnitine, tea polyphenols, hydroxypropyl cellulose and microcrystalline cellulose evenly, and put them in a fluidized bed granulator to granulate, the water content of the granules is less than 5%. Sieve through a 30-mesh sieve, add magnesium stearate, and fill the mixed granules into capsules. The amount of each capsule is 250 mg. Adult dosage: 3-4g / day.

Embodiment 2

[0066] Embodiment 2, calcium conjugated linoleate hard capsule

[0067] Material weighing: calcium conjugated linoleate 50g, acetyl-L-carnitine 100g, THBQ 0.02g, hypromellose 0.7g, microcrystalline cellulose 1.2g, magnesium stearate 0.5g.

[0068] Mix the weighed calcium conjugated linoleate, acetyl-L-carnitine, THBQ, hydroxypropyl cellulose and microcrystalline cellulose evenly, and granulate in a fluidized bed granulator. The moisture content of the granules is less than 5%, 30 mesh Sieve the granules, add magnesium stearate, mix the granules and fill them into capsules, each with a loading capacity of 250mg.

Embodiment 3

[0069] Embodiment 3, calcium conjugated linoleate hard capsule

[0070] Material weighing: calcium conjugated linoleate 100g, L-carnitine tartrate 25g, vitamin E 0.03g, hydroxypropyl cellulose 1g, microcrystalline cellulose 1g, magnesium stearate 0.5g.

[0071] Mix the weighed calcium conjugated linoleate, L-carnitine tartrate, vitamin E, hydroxypropyl cellulose and microcrystalline cellulose evenly, and granulate in a fluidized bed granulator. The moisture content of the granules is less than 5%. , 30-mesh sieve, add magnesium stearate, mix the granules and fill them into capsules, each with a loading capacity of 250mg.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound preparation for fat-reducing, antihyperglycemic, antihypelipidemic and osteoporosis in medical domain, which is characterized by the following: setting mass ratio of adjoint linolic acid calcium and left-handed carnitine or derivation of adjoint linolic acid calcium and left-handed carnitine at 4 : 1-8; producing to tablet, capsule, powder medicine and granula with compound preparation. This invention possesses simple preparation and convenient usage.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the medicine for weight loss, blood fat reduction, blood sugar reduction, blood pressure reduction, and prevention and treatment of osteoporosis, which contains conjugated calcium linoleate and L-carnitine or conjugated calcium linoleate and L-carnitine derivatives compound preparations. Background technique [0002] With the rapid development of society and the improvement of people's living standards, many modern diseases such as obesity, hypertension, hyperlipidemia, diabetes, and osteoporosis are threatening human health. The prevention and treatment of modern diseases has become a concern of human beings. Obesity and the "three highs" (hypertension, hyperlipidemia and hyperglycemia) often occur in the same body and have become a worldwide epidemic. Disease comes first. Obese people often have disorders of lipid metabolism and glucose metabolism. Diabetics are also accompanied by h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/205A61K9/14A61K9/16A61K9/20A61K9/48A61K47/08A61K47/10A61K47/22A61K47/46A61P3/04A61P3/06A61P3/10A61P9/12A61P19/10A61K31/201
Inventor 杨得坡梁淑明李珍冀军峰曾晓晖鲁冰山
Owner ZHONGSHAN UNICARE NATURAL MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com